Accuray

Update in progress

ARAY (NasdaqCM)

Company RatingNeutral
SectorHealthcare
IndustryMedical Devices

Accuray designs, develops, makes, and sells radiosurgery and radiation therapy systems for tumors worldwide. Its CyberKnife robotic radiosurgery treats primary and metastatic tumors outside the brain, including spine, breast, kidney, liver, lung, pancreas, and prostate. TomoTherapy with Radixact enables integrated planning, delivery, and data management. It also offers iDMS, precision planning, and post-sale support, installation, and training. Headquartered in Madison, Wisconsin.

Company score

Sentiment: 0.11; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: -0.05; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.08; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.00; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.06; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive